NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals Technologies Group, Inc. (NasdaqGM: SHLS), if they purchased or otherwise acquired the Company’s shares between May 17, 2022 and November 7, 2023, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals Technologies Group, Inc. (NasdaqGM: SHLS), if they purchased or otherwise acquired the Company’s shares between May 17, 2022 and November 7, 2023, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Middle District of Tennessee.
- Shoals investors should visit us at https://claimsfiler.com/cases/nasdaq-shls/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero Therapeutics, Inc. (NasdaqGS: AKRO), if they purchased or otherwise acquired the Company’s shares between September 13, 2022 and October 9, 2023, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero Therapeutics, Inc. (NasdaqGS: AKRO), if they purchased or otherwise acquired the Company’s shares between September 13, 2022 and October 9, 2023, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Northern District of California.
- Akero Therapeutics investors should visit us at https://claimsfiler.com/cases/nasdaq-akro/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company’s shares between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE: DOCS), if they purchased or otherwise acquired the Company’s shares between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Northern District California.
- Doximity investors should visit us at https://claimsfiler.com/cases/nyse-docs/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL), if they: i) purchased or otherwise acquired the Company’s shares between April 15, 2021 and February 27, 2024, inclusive (the “Class Period”), and/or ii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s April 2021 initial public offering (“IPO”), and/or iii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s May 2023 secondary public offering (“SPO”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL), if they: i) purchased or otherwise acquired the Company’s shares between April 15, 2021 and February 27, 2024, inclusive (the “Class Period”), and/or ii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s April 2021 initial public offering (“IPO”), and/or iii) purchased or otherwise acquired the Company’s shares pursuant or traceable to the Company’s May 2023 secondary public offering (“SPO”).
- These actions are pending in the United States District Courts for the Western District of Texas and Southern District of New York.
- Agilon health investors should visit us at https://www.claimsfiler.com/cases/nyse-agl or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE: CC), if they purchased or otherwise acquired the Company’s shares between February 10, 2023, and February 28, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 20, 2024 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (NYSE: CC), if they purchased or otherwise acquired the Company’s shares between February 10, 2023, and February 28, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the District of Delaware.
- Chemours investors should visit us at https://www.claimsfiler.com/cases/nyse-cc-2 or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 24, 2024 to file lead plaintiff applications in a securities class action lawsuit against Autodesk, Inc. (NasdaqGS: ADSK), if they purchased or otherwise acquired the Company’s securities between June 1, 2023 and April 16, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 24, 2024 to file lead plaintiff applications in a securities class action lawsuit against Autodesk, Inc. (NasdaqGS: ADSK), if they purchased or otherwise acquired the Company’s securities between June 1, 2023 and April 16, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Northern District of California.
- Autodesk investors should visit us at https://claimsfiler.com/cases/nasdaq-adsk-1/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining Inc. (NasdaqGS: SSRM), if they purchased the Company’s securities between February 23, 2022 and February 27, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining Inc. (NasdaqGS: SSRM), if they purchased the Company’s securities between February 23, 2022 and February 27, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the District of Colorado.
- SSR investors should visit us at https://claimsfiler.com/cases/nasdaq-ssrm/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
Long term holders of GL are also encouraged to contact the firm.
Key Points:
- Long term holders of GL are also encouraged to contact the firm.
- This action is pending in the United States District Court for the Eastern District of Texas.
- Globe Life investors should visit us at https://claimsfiler.com/cases/nyse-gl/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Perion Network Ltd. (NasdaqGS: PERI), if they purchased or otherwise acquired the Company’s shares between February 9, 2021 and April 5, 2024, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Perion Network Ltd. (NasdaqGS: PERI), if they purchased or otherwise acquired the Company’s shares between February 9, 2021 and April 5, 2024, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Southern District of New York.
- Perion investors should visit us at https://claimsfiler.com/cases/nasdaq-peri/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 24, 2024 to file lead plaintiff applications in a securities class action lawsuit against Lincoln National Corporation (NYSE: LNC), if they purchased or otherwise acquired the Company’s securities between November 4, 2020 and November 2, 2022, inclusive (the “Class Period”).
Key Points:
- NEW ORLEANS, May 08, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 24, 2024 to file lead plaintiff applications in a securities class action lawsuit against Lincoln National Corporation (NYSE: LNC), if they purchased or otherwise acquired the Company’s securities between November 4, 2020 and November 2, 2022, inclusive (the “Class Period”).
- This action is pending in the United States District Court for the Eastern District of Pennsylvania.
- Lincoln National investors should visit us at https://claimsfiler.com/cases/nyse-lnc/ or call toll-free (844) 367-9658.
- Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
